Search results for "randomized controlled trials"

showing 10 items of 449 documents

Reperfusion of liver graft during transplantation: techniques used in transplant centres within Eurotransplant and meta-analysis of the literature

2013

Abstract: It remains unclear which liver graft reperfusion technique leads to the best outcome following transplantation. An online survey was sent to all transplant centres (n=37) within Eurotransplant (ET) to collect information on their technique used for reperfusion of liver grafts. Furthermore, a systematic review of all literature was performed and a meta-analysis was conducted based on patients' mortality, number of retransplantations and incidence of biliary complications, depending on the technique used. Of the 28 evaluated centres, 11 (39%) reported performing simultaneous reperfusion (SIMR), 13 (46%) perform initial portal vein reperfusion (IPR), 1 (4%) performs an initial hepati…

medicine.medical_specialtyVena cavamedicine.medical_treatmentPortal veinMedizin030230 surgeryRevascularizationVenovenous bypassretrograde reperfusionlaw.invention03 medical and health sciences0302 clinical medicineHepatic ArteryRandomized controlled triallawSurveys and QuestionnairesMedicineHumansRandomized Controlled Trials as TopicTransplantationbusiness.industryPortal Veinsimultaneous reperfusion3. Good healthSurgeryLiver TransplantationTransplantationLiver graftEuropeTreatment OutcomeMeta-analysisReperfusion030211 gastroenterology & hepatologyHuman medicineliver reperfusionbusinesssequential reperfusionLiver Circulation
researchProduct

Antivitamin K Drugs in Stroke Prevention

2014

Among the different subtypes of ischaemic strokes, almost 20 % are of cardiac origin. Different are the causes of cardioembolic stroke, but the most common is the atrial fibrillation, a supraventricular arrhythmia. Appropriate use of antiplatelet drugs and anticoagulants after transient ischaemic attack (TIA) or ischaemic stroke depends on whether the underlying cause is cardioembolic or of presumed arterial origin. Adequate antiplatelet therapy is recommended for secondary prevention after cerebral ischaemia of presumed arterial origin, whether for patients with TIA and ischaemic stroke of cardiac origin, mainly due to atrial fibrillation. Vitamin K antagonists (VKAs) are highly effective …

medicine.medical_specialtyVitamin KSettore MED/09 - Medicina InternaAppropriate useInternal medicinemedicineAnimalsHumanscardiovascular diseasesRandomized Controlled Trials as TopicPharmacologySupraventricular arrhythmiabusiness.industryPatient choiceStandard treatmentAnticoagulantsVKAs Stroke preventionAtrial fibrillationmedicine.diseaseStrokeIschemic Attack TransientStroke preventionCardiologyCerebral ischaemiaCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation InhibitorsDiscovery and development of direct thrombin inhibitorsCurrent Vascular Pharmacology
researchProduct

Direct Oral Anticoagulants in the Setting of Catheter Ablation of Atrial Fibrillation: State of art

2021

Atrial fibrillation (AF) represents the arrhythmia of greatest clinical impact and catheter ablation of AF (CAAF) has become the most effective strategy for rhythm control in selected patients. Therefore, appropriate anticoagulation strategies are of paramount importance for patients undergoing CAAF, especially those at high risk, such those with high CHA2DS2VASc scores. Optimal management of anticoagulation before, during, and after CAAF is crucial. Several studies have evaluated the use of different anticoagulation strategies in the periprocedural period. Randomized controlled trial seem to suggest that in patients undergoing CAAF, uninterrupted (or minimally interrupted) direct oral anti…

medicine.medical_specialtyVitamin Kmedicine.medical_treatmentAdministration OralRhythm controlCatheter ablation030204 cardiovascular system & hematologyVitamin klaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineVitamin K/administration & dosagecatheter ablationmedicineHumansrisk factorsIn patientatrial fibrillation030212 general & internal medicineanticoagulationRandomized Controlled Trials as TopicAnticoagulants/administration & dosagebusiness.industryAnticoagulantsAtrial fibrillationGeneral Medicinemedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareOptimal managementTreatment OutcomeState of artCardiologybusinessCardiology and Cardiovascular MedicineAtrial Fibrillation/complications
researchProduct

Investigational agents for Crohn's disease.

2010

IMPORTANCE OF THE FIELD: Increased understanding of the biological mechanisms of Crohn's disease has opened the door to a large number of new molecules; some of these are approved for clinical use, while others remain under evaluation. In this review, we examine the clinical efficacy of all the new drugs that have been evaluated in controlled trials in the last 12 years. AREAS COVERED IN THIS REVIEW: Anti-TNF therapy has been reviewed briefly, given the many comprehensive reviews on this topic; attention is focused mainly on the other biological therapies. In assessing the clinical efficacy of these molecules, we consider only the remission rate, as this is considered the most meaningful en…

medicine.medical_specialtybiological therapy. Crohn' s disease. Integrins.Probiotics.Small molecules.DiseaseAdaptive ImmunityReceptors Tumor Necrosis FactorCrohn DiseaseGastrointestinal AgentsmedicineHumansImmunologic FactorsPharmacology (medical)Clinical efficacyIntensive care medicineRandomized Controlled Trials as TopicPharmacologyMitogen-Activated Protein Kinase KinasesBiological therapiesCrohn's diseaseEverolimusEnd pointINVESTIGATIONAL AGENTSbusiness.industryRemission InductionAntibodies MonoclonalGeneral MedicineDrugs Investigationalmedicine.diseaseImmunity InnateImmunologyCytokinesRemission rateImmunotherapybusinessCell Adhesion Moleculesmedicine.drugExpert opinion on investigational drugs
researchProduct

Potential options to optimize therapy of gastroesophageal reflux disease with proton pump inhibitors.

2007

Proton pump inhibitors (PPIs) are antisecretory agents that are widely used in the short- and long-term management of gastroesophageal reflux disease (GERD) to relieve symptoms, heal esophagitis, and prevent complications, such as strictures and Barrett’s esophagus. The total healthcare costs of GERD are high, especially for maintenance treatment. Therefore, the choice of cost-effective therapeutic options is an ineluctable challenge for public health authorities, third-party payers, and patients. In some European Union countries, a recent trend of public health authorities is to promote the choice of less expensive PPIs, regardless of their antisecretory potency – this in spite of the evid…

medicine.medical_specialtybusiness.industryGastroenterologyRefluxAntisecretory agentsEsomeprazoleProton Pump InhibitorsDiseaseProton pump inhibitorGastroesophageal reflux diseasemedicine.diseaseGastroenterologydigestive system diseasesInternal medicineGERDmedicineGastroesophageal RefluxHumansbusinessEsophagitisTherapy optimizationRandomized Controlled Trials as TopicDigestion
researchProduct

Methodological matters on an Alzheimer's dementia trial: is a double-blind randomized controlled study design sufficient to draw strong conclusions o…

2007

medicine.medical_specialtybusiness.industryGinkgo bilobamedicine.diseaselaw.inventionDouble blindNeurologyRandomized controlled trialDouble-Blind MethodPiperidineslawAlzheimer DiseaseIndansmedicineDementiaHumansAlzheimer s dementiaDementiaDonepezilNeurology (clinical)Cholinesterase InhibitorsPsychiatrybusinessRandomized Controlled Trials as TopicEuropean journal of neurology
researchProduct

Cardiovascular consequences of sleep disordered breathing: the role of CPAP treatment

2020

CPAP treatment decreases BP in OSA patients, especially in severe OSA, and in patients with poorly controlled BP. OSA adversely affects heart function and remodelling, but its role in the pathogenesis of HF remains unclear. Similarly, the impact of CPAP is uncertain, and results of the ongoing ADVENT-HF trial will provide more information. Several experimental studies in animals and humans indicate a central role of intermittent hypoxia in atherogenesis through multiple mechanisms. However, randomised controlled trials (RCTs) in patients with CAD and OSA found no difference in outcomes between CPAP-treated and untreated patients. The negative results of secondary prevention RCTs may be the …

medicine.medical_specialtybusiness.industryInternal medicinerandomized controlled trialsSleep disordered breathingCardiologyblood pressureMedicineCpap treatmentSettore MED/10 - Malattie Dell'Apparato Respiratorioarrhythmiabusiness
researchProduct

Chronic total coronary occlusions and the Occluded Artery Trial. A critical appraisal.

2008

The OAT trial and its angiographic substudy TOSCA-2, along with a number of published commentaries, represents examples of over-interpretation of clinical study results. A study that achieved no statistically significant result for any of the study endpoints can only claim to have proven that their null hypothesis cannot be rejected. The lack of power due to a reduction of patient numbers by one third, and an unexpected low event rate, makes it not unlikely that another trial would be able to disprove the null hypothesis. These statistical facts should be accepted by the authors and commentators. Instead, the inconclusive results were interpreted in such a way that they might apply to patie…

medicine.medical_specialtybusiness.industryMyocardial Infarctionocclusions.Critical appraisalmedicine.anatomical_structureCoronary OcclusionInternal medicinemedicineCardiologyHumansChronicCardiology and Cardiovascular MedicinebusinesscoronaryRandomized Controlled Trials as TopicArteryEuroIntervention
researchProduct

Enteral Nutrition in Pancreaticoduodenectomy: A Literature Review

2015

Pancreaticoduodenectomy (PD) is considered the gold standard treatment for periampullory carcinomas. This procedure presents 30%–40% of morbidity. Patients who have undergone pancreaticoduodenectomy often present perioperative malnutrition that is worse in the early postoperative days, affects the process of healing, the intestinal barrier function and the number of postoperative complications. Few studies focus on the relation between enteral nutrition (EN) and postoperative complications. Our aim was to perform a review, including only randomized controlled trial meta-analyses or well-designed studies, of evidence regarding the correlation between EN and main complications and outcomes af…

medicine.medical_specialtydelayed gastric emptyingGastroparesismedicine.medical_treatmentlcsh:TX341-641ReviewPancreaticoduodenectomylaw.inventionPancreatic FistulaEnteral NutritionPostoperative ComplicationsMeta-Analysis as TopicRandomized controlled trialRisk FactorslawmedicineHumansGastroparesisRandomized Controlled Trials as TopicNutrition and DieteticsGastric emptyingEnteral nutrition; pancreaticoduodenectomy; delayed gastric emptying; postoperative pancreatic fistula; postpancreatectomy hemorrhagebusiness.industryGeneral surgeryGold standardPerioperativeLength of Staymedicine.diseasePancreaticoduodenectomySurgerySettore MED/18 - Chirurgia GeneraleTreatment OutcomeParenteral nutritionPancreatic fistulapostoperative pancreatic fistulabusinesslcsh:Nutrition. Foods and food supplypostpancreatectomy hemorrhageFood ScienceNutrients
researchProduct

The efficacy of muscle energy techniques in symptomatic and asymptomatic subjects: a systematic review

2019

Abstract Background Muscle energy techniques are applied to reduce pain and increase range of motion. These are applied to a variety of pathological conditions and on asymptomatic subjects. There is however limited knowledge on their effectiveness and which protocol may be the most beneficial. Objective The aim of this review is to determine the efficacy of muscle energy techniques (MET) in symptomatic and asymptomatic subjects. Design Systematic Review. Methods A literature search was performed using the following database: Cochrane Library, MEDLINE, NLM Pubmed and ScienceDirect. Studies regarding MET in asymptomatic and symptomatic patients were considered for investigation. The main outc…

medicine.medical_specialtylcsh:Diseases of the musculoskeletal systemmedicine.medical_treatmentMEDLINEPainPhysical Therapy Sports Therapy and RehabilitationCochrane LibraryAsymptomaticlaw.invention03 medical and health sciencesManipulative therapie0302 clinical medicineRandomized controlled triallawMedicineHumans030212 general & internal medicineRange of Motion ArticularPathologicalRange of motionRandomized Controlled Trials as TopicRehabilitationbusiness.industryEpicondylitisMuscleslcsh:Chiropracticmedicine.diseaseManipulation OsteopathicAcute PainTreatment OutcomeComplementary and alternative medicinelcsh:RZ201-275Asymptomatic DiseasesPhysical therapyChiropracticsSystematic Reviewlcsh:RC925-935medicine.symptomChronic PainRange of motionbusinessManipulative therapies030217 neurology & neurosurgeryChiropractic & Manual Therapies
researchProduct